You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

imfinzi

Showing 1 - 25 of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -

Not yet recruiting
  • Biliary Tract Cancer
    • (no location specified)
    Apr 26, 2023

    Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing

    Not yet recruiting
    • Unresectable Hepatocellular Carcinoma
      • (no location specified)
      Dec 19, 2022

      Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        Apr 21, 2023

        EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

        Recruiting
        • EGFR-Mutated Non-Small-Cell Lung Carcinoma
        • Small Cell/Neuroendocrine
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 20, 2023

        NSCLC Trial in Beijing (Durvalumab, Albumin Paclitaxel, Carboplatin/Cisplatin)

        Recruiting
        • Non-small Cell Lung Cancer
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Apr 21, 2022

        Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

        Not yet recruiting
        • Pancreatic Ductal Adenocarcinoma
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Sep 22, 2023

        Carcinoma, Small Cell Trial in Japan

        Active, not recruiting
        • Carcinoma, Small Cell
          • Aichi, Japan
          • +29 more
          Dec 6, 2022

          Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

          Not yet recruiting
          • Non Small Cell Lung Cancer
          • carboplatin chemotherapy
          • +2 more
          • Salt Lake City, Utah
            Huntsman Cancer Institute
          Nov 3, 2023

          Hepatocellular Carcinoma Trial in Chicago, New York (TheraSphere Y-90 glass microsphere therapy, Durvalumab (Imfinzi)

          Recruiting
          • Hepatocellular Carcinoma
          • TheraSphere Y-90 glass microsphere therapy
          • +2 more
          • Washington, District of Columbia
          • +7 more
          Jan 17, 2023

          Unresectable Hepatocellular Carcinoma Trial (Durvalumab, Tremelimumab)

          Available
          • Unresectable Hepatocellular Carcinoma
          • (no location specified)
          Aug 12, 2022

          Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

          Not yet recruiting
          • Hepatocellular Carcinoma (HCC)
          • (no location specified)
          Sep 11, 2023

          Fibrolamellar Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, DRP-104)

          Not yet recruiting
          • Fibrolamellar Hepatocellular Carcinoma
          • Baltimore, Maryland
            Johns Hopkins SKCCC
          Aug 30, 2023

          Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)

          Recruiting
          • Pancreatic Cancer
          • Sydney, New South Wales, Australia
          • +2 more
          Oct 19, 2023

          Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

          Not yet recruiting
          • Metastatic Pancreatic Cancer
          • Durvalumab
          • Rintatolimod
          • Rotterdam, Zuid-Holland, Netherlands
            Erasmus MC
          Jun 23, 2023

          Biliary Tract Cancers Trial (durvalumab)

          Not yet recruiting
          • Biliary Tract Cancers
          • (no location specified)
          Jun 20, 2023

          Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

          Recruiting
          • Stomach Cancer, Adenocarcinoma
          • Seoul, Korea, Republic of
            Samsung Medical Center
          Jan 10, 2023

          Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

          Not yet recruiting
          • Pancreatic Cancer
          • +3 more
          • Durvalumab
          • +5 more
          • Edmonton, Alberta, Canada
            Cross Cancer Institute
          Feb 1, 2023

          Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

          Not yet recruiting
          • Resectable Hepatocellular Carcinoma
          • +2 more
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Jan 18, 2023

          Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

          Not yet recruiting
          • Small Cell Lung Cancer
          • +2 more
          • (no location specified)
          Jun 5, 2023

          Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

          Recruiting
          • Premenopausal Breast Cancer
          • +2 more
          • Taipei City, Taiwan
            Department of Oncology, National Taiwan University Hospital
          Feb 7, 2023

          Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

          Not yet recruiting
          • Bile Duct Cancer
          • +4 more
          • Boston, Massachusetts
            Beth Israel Deaconess Medical Center
          Jan 23, 2023

          Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)

          Recruiting
          • Triple Negative Breast Cancer Metastatic
          • Milano, Italy
          • +1 more
          Jan 16, 2023

          Breast Cancer Trial in Houston (Durvalumab, Trastuzumab, Pertuzumab)

          Recruiting
          • Breast Cancer
          • Houston, Texas
            Houston Methodist Cancer Center
          Aug 5, 2022

          Urothelial Carcinoma Trial in Amsterdam (Tremelimumab, Durvalumab, Paclitaxel)

          Active, not recruiting
          • Urothelial Carcinoma
          • Amsterdam, Netherlands
            Antoni van Leeuwenhoek Ziekenhuis
          Jul 7, 2022

          Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)

          Recruiting
          • Urothelial Carcinoma
          • Bladder Cancer
          • Durvalumab (Cohort 1-3)
          • +7 more
          • Phoenix, Arizona
          • +10 more
          Jan 11, 2023